Go Pro
→ Buy this stock tomorrow (From Chaikin Analytics) (Ad)tc pixel Free NAII Stock Alerts

Natural Alternatives International (NAII) Competitors

Natural Alternatives International logo
$2.32 +0.05 (+2.20%)
Closing price 08/4/2026 04:00 PM Eastern
Extended Trading
$2.34 +0.02 (+0.65%)
As of 08/4/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

NAII vs. XLO, CLNN, ANVS, SCLX, and PMVP

Should you buy Natural Alternatives International stock or one of its competitors? MarketBeat compares Natural Alternatives International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Natural Alternatives International include Xilio Therapeutics (XLO), Clene (CLNN), Annovis Bio (ANVS), Scilex (SCLX), and PMV Pharmaceuticals (PMVP).

How does Natural Alternatives International compare to Xilio Therapeutics?

Xilio Therapeutics (NASDAQ:XLO) and Natural Alternatives International (NASDAQ:NAII) are related small-cap companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

Natural Alternatives International has a net margin of -10.13% compared to Xilio Therapeutics' net margin of -58.52%. Natural Alternatives International's return on equity of -12.21% beat Xilio Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Xilio Therapeutics-58.52% -151.42% -27.61%
Natural Alternatives International -10.13%-12.21%-5.30%

54.3% of Xilio Therapeutics shares are held by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are held by institutional investors. 7.5% of Xilio Therapeutics shares are held by insiders. Comparatively, 20.8% of Natural Alternatives International shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Natural Alternatives International has higher revenue and earnings than Xilio Therapeutics. Xilio Therapeutics is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Xilio Therapeutics$43.77M1.37-$35.04M-$3.55N/A
Natural Alternatives International$129.86M0.11-$13.57M-$2.39N/A

Xilio Therapeutics has a beta of -0.14, suggesting that its stock price is 114% less volatile than the broader market. Comparatively, Natural Alternatives International has a beta of 0.36, suggesting that its stock price is 64% less volatile than the broader market.

In the previous week, Xilio Therapeutics had 2 more articles in the media than Natural Alternatives International. MarketBeat recorded 2 mentions for Xilio Therapeutics and 0 mentions for Natural Alternatives International. Xilio Therapeutics' average media sentiment score of 0.00 equaled Natural Alternatives International'saverage media sentiment score.

Company Overall Sentiment
Xilio Therapeutics Neutral
Natural Alternatives International Neutral

Xilio Therapeutics currently has a consensus target price of $28.00, suggesting a potential upside of 208.03%. Given Xilio Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe Xilio Therapeutics is more favorable than Natural Alternatives International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Xilio Therapeutics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
Natural Alternatives International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Natural Alternatives International beats Xilio Therapeutics on 9 of the 15 factors compared between the two stocks.

How does Natural Alternatives International compare to Clene?

Clene (NASDAQ:CLNN) and Natural Alternatives International (NASDAQ:NAII) are related small-cap companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Natural Alternatives International has higher revenue and earnings than Clene. Clene is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clene$200K337.39-$26.17M-$3.20N/A
Natural Alternatives International$129.86M0.11-$13.57M-$2.39N/A

In the previous week, Clene had 1 more articles in the media than Natural Alternatives International. MarketBeat recorded 1 mentions for Clene and 0 mentions for Natural Alternatives International. Clene's average media sentiment score of 0.00 equaled Natural Alternatives International'saverage media sentiment score.

Company Overall Sentiment
Clene Neutral
Natural Alternatives International Neutral

Clene has a beta of 0.96, meaning that its stock price is 4% less volatile than the broader market. Comparatively, Natural Alternatives International has a beta of 0.36, meaning that its stock price is 64% less volatile than the broader market.

Clene currently has a consensus target price of $33.25, suggesting a potential upside of 529.73%. Given Clene's stronger consensus rating and higher probable upside, research analysts clearly believe Clene is more favorable than Natural Alternatives International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clene
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.71
Natural Alternatives International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

23.3% of Clene shares are owned by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are owned by institutional investors. 28.3% of Clene shares are owned by insiders. Comparatively, 20.8% of Natural Alternatives International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Natural Alternatives International has a net margin of -10.13% compared to Clene's net margin of -25,009.70%. Clene's return on equity of 0.00% beat Natural Alternatives International's return on equity.

Company Net Margins Return on Equity Return on Assets
Clene-25,009.70% N/A -137.98%
Natural Alternatives International -10.13%-12.21%-5.30%

Summary

Clene beats Natural Alternatives International on 8 of the 15 factors compared between the two stocks.

How does Natural Alternatives International compare to Annovis Bio?

Annovis Bio (NYSE:ANVS) and Natural Alternatives International (NASDAQ:NAII) are related small-cap companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

Annovis Bio has a net margin of 0.00% compared to Natural Alternatives International's net margin of -10.13%. Natural Alternatives International's return on equity of -12.21% beat Annovis Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Annovis BioN/A -318.08% -215.47%
Natural Alternatives International -10.13%-12.21%-5.30%

Natural Alternatives International has higher revenue and earnings than Annovis Bio. Annovis Bio is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Annovis BioN/AN/A-$28.85M-$1.71N/A
Natural Alternatives International$129.86M0.11-$13.57M-$2.39N/A

Annovis Bio has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market. Comparatively, Natural Alternatives International has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market.

Annovis Bio currently has a consensus price target of $11.67, indicating a potential upside of 522.22%. Given Annovis Bio's stronger consensus rating and higher probable upside, equities research analysts clearly believe Annovis Bio is more favorable than Natural Alternatives International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Annovis Bio
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.60
Natural Alternatives International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

15.8% of Annovis Bio shares are owned by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are owned by institutional investors. 20.8% of Annovis Bio shares are owned by company insiders. Comparatively, 20.8% of Natural Alternatives International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Annovis Bio had 2 more articles in the media than Natural Alternatives International. MarketBeat recorded 2 mentions for Annovis Bio and 0 mentions for Natural Alternatives International. Annovis Bio's average media sentiment score of 0.67 beat Natural Alternatives International's score of 0.00 indicating that Annovis Bio is being referred to more favorably in the media.

Company Overall Sentiment
Annovis Bio Positive
Natural Alternatives International Neutral

Summary

Annovis Bio beats Natural Alternatives International on 9 of the 15 factors compared between the two stocks.

How does Natural Alternatives International compare to Scilex?

Natural Alternatives International (NASDAQ:NAII) and Scilex (NASDAQ:SCLX) are related small-cap companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natural Alternatives International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Scilex
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Natural Alternatives International has a net margin of -10.13% compared to Scilex's net margin of -1,110.17%. Scilex's return on equity of 0.00% beat Natural Alternatives International's return on equity.

Company Net Margins Return on Equity Return on Assets
Natural Alternatives International-10.13% -12.21% -5.30%
Scilex -1,110.17%N/A -143.55%

Natural Alternatives International has a beta of 0.36, indicating that its share price is 64% less volatile than the broader market. Comparatively, Scilex has a beta of 1.67, indicating that its share price is 67% more volatile than the broader market.

32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 69.7% of Scilex shares are held by institutional investors. 20.8% of Natural Alternatives International shares are held by company insiders. Comparatively, 4.5% of Scilex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Natural Alternatives International has higher revenue and earnings than Scilex. Natural Alternatives International is trading at a lower price-to-earnings ratio than Scilex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natural Alternatives International$129.86M0.11-$13.57M-$2.39N/A
Scilex$30.25M1.82-$358.73M-$40.47N/A

In the previous week, Scilex had 1 more articles in the media than Natural Alternatives International. MarketBeat recorded 1 mentions for Scilex and 0 mentions for Natural Alternatives International. Scilex's average media sentiment score of 0.67 beat Natural Alternatives International's score of 0.00 indicating that Scilex is being referred to more favorably in the news media.

Company Overall Sentiment
Natural Alternatives International Neutral
Scilex Positive

Summary

Scilex beats Natural Alternatives International on 7 of the 13 factors compared between the two stocks.

How does Natural Alternatives International compare to PMV Pharmaceuticals?

PMV Pharmaceuticals (NASDAQ:PMVP) and Natural Alternatives International (NASDAQ:NAII) are related small-cap companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

Natural Alternatives International has higher revenue and earnings than PMV Pharmaceuticals. Natural Alternatives International is trading at a lower price-to-earnings ratio than PMV Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PMV PharmaceuticalsN/AN/A-$77.74M-$1.49N/A
Natural Alternatives International$129.86M0.11-$13.57M-$2.39N/A

PMV Pharmaceuticals has a beta of 1.34, meaning that its share price is 34% more volatile than the broader market. Comparatively, Natural Alternatives International has a beta of 0.36, meaning that its share price is 64% less volatile than the broader market.

PMV Pharmaceuticals has a net margin of 0.00% compared to Natural Alternatives International's net margin of -10.13%. Natural Alternatives International's return on equity of -12.21% beat PMV Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
PMV PharmaceuticalsN/A -68.98% -62.70%
Natural Alternatives International -10.13%-12.21%-5.30%

90.2% of PMV Pharmaceuticals shares are held by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are held by institutional investors. 10.2% of PMV Pharmaceuticals shares are held by insiders. Comparatively, 20.8% of Natural Alternatives International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, PMV Pharmaceuticals had 1 more articles in the media than Natural Alternatives International. MarketBeat recorded 1 mentions for PMV Pharmaceuticals and 0 mentions for Natural Alternatives International. PMV Pharmaceuticals' average media sentiment score of 0.86 beat Natural Alternatives International's score of 0.00 indicating that PMV Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
PMV Pharmaceuticals Positive
Natural Alternatives International Neutral

PMV Pharmaceuticals presently has a consensus target price of $4.00, indicating a potential upside of 241.88%. Given PMV Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts clearly believe PMV Pharmaceuticals is more favorable than Natural Alternatives International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PMV Pharmaceuticals
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.75
Natural Alternatives International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

PMV Pharmaceuticals beats Natural Alternatives International on 11 of the 16 factors compared between the two stocks.

Get Natural Alternatives International News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAII vs. The Competition

Export
MetricNatural Alternatives InternationalPersonal Care Products IndustryConsumer Staples SectorNASDAQ Exchange
Market Cap$14.24M$22.79B$16.18B$12.76B
Dividend YieldN/A4.15%3.20%10.01%
P/E Ratio-0.9719.5314.5325.53
Price / Sales0.1112.70262,279.5394.29
Price / CashN/A29.1857.6749.39
Price / Book0.212.894.686.11
Net Income-$13.57M$1.08B$841.31M$347.58M
7 Day Performance4.50%2.77%0.26%4.91%
1 Month Performance-2.11%-1.96%-0.59%-2.06%
1 Year Performance-36.51%-17.22%14.06%21.03%

Natural Alternatives International Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAII
Natural Alternatives International
0.4971 of 5 stars		$2.32
+2.2%		N/A-37.5%$14.24M$129.86MN/A290
XLO
Xilio Therapeutics
1.4407 of 5 stars		$9.04
-1.2%		$28.00
+209.6%		-1.2%$59.50M$43.77MN/A70
CLNN
Clene
2.0718 of 5 stars		$4.64
-7.1%		$33.25
+617.4%		+41.2%$59.24M$200KN/A100
ANVS
Annovis Bio
3.1959 of 5 stars		$1.71
+0.9%		$11.67
+584.3%		-30.0%$59.08MN/AN/A3
SCLX
Scilex
0.493 of 5 stars		$6.82
flat		N/A-56.8%$57.91M$30.25MN/A80

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NAII) was last updated on 8/5/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel